U.S. Semiconductors Stock News

In the latest month, FedEx (NYSE:FDX) experienced a share price increase of 6%, which aligns with the recent 1.9% climb in the broader market. The company's fourth-quarter earnings announcement on June 24, 2025, highlighted a 5% increase in diluted EPS, reinforcing positive investor sentiment. Additionally, the company's share buyback activities, where FedEx repurchased roughly 0.84% of its outstanding shares, likely contributed to investor optimism. Nonetheless, the unfortunate passing of...

Salesforce (NYSE:CRM) recently announced two impactful initiatives: PepsiCo's adoption of Agentforce to enhance operational efficiency and customer support, and UChicago Medicine's implementation of Agentforce for Health, aimed at improving patient experiences. These developments underscore the company's commitment to AI integration in diverse industries. Last week, Salesforce's share price rose 4.5%, notably outpacing the broader market's 1.9% climb. The favorable reception of these client...

PayPal Holdings (NasdaqGS:PYPL) experienced a price movement of 7% over the past week, aligning closely with broader market trends, where the market saw a 2% rise. This movement came amid significant developments, such as the announcement of a partnership with Taco Bell to offer flexible payment options, including cashback rewards, potentially enhancing user engagement. Furthermore, the appointment of Deirdre Stanley to the board and a restructuring of board committees represents a focus on...

Stryker (NYSE:SYK) recently received FDA clearance for its Incompass® Total Ankle System, a significant product innovation that highlights the company's commitment to advancing patient care. Over the last quarter, Stryker's stock price moved up by 5%, a performance that comfortably exceeds the broader market's 1.9% increase over the same period. While the FDA clearance news likely supported this uptrend, other developments—such as the company's robust Q1 earnings and increased dividend...

Starbucks (NasdaqGS:SBUX) is contemplating a potential sale of its China operations, amidst significant market challenges. The company's share price moved 8% last month, a notable increase compared to the broader market's 2% rise in the past week. Several events likely influenced this movement: discussions of selling a stake in its China business, a new credit facility, and the appointment of a new COO. Meanwhile, ongoing legal issues may have had a counteracting effect. These developments,...

Marriott International (NasdaqGS:MAR) recently announced a multi-unit agreement to introduce four new City Express by Marriott properties in El Salvador, marking the brand's entry into the country. The expansion aligns with Marriott's growth strategy in the Caribbean and Latin America region. During the last quarter, Marriott's stock price rose by nearly 10%, a notable increase compared to the market's 12% rise over the past 12 months. The company's robust earnings growth and strategic market...

Gilead Sciences (NasdaqGS:GILD) recently entered an exclusive agreement with Kymera Therapeutics to advance a molecular glue degrader program targeting CDK2, enhancing its oncology pipeline. Additionally, the FDA approved Yeztugo as a breakthrough HIV prevention option. Both events underscore Gilead's strength in innovation. Despite these developments, Gilead's share price remained flat over the past month, contrasting with the broader market's 1.9% rise in seven days. While these initiatives...

Exelixis (NasdaqGS:EXEL) recently announced positive topline results from the STELLAR-303 Phase 3 trial, highlighting the effectiveness of zanzalintinib in combination with atezolizumab for treating certain colorectal cancers, which likely fueled its 24% share price increase over the last quarter. The company's strong financial performance, including significant revenue and net income growth, likely provided additional support to this positive momentum. Market conditions were generally...

Apple (NasdaqGS:AAPL) is currently facing significant legal challenges, with a recent lawsuit alleging violations of federal securities laws over misrepresentations related to Siri’s AI features on the upcoming iPhone 16. Despite these challenges, Apple's stock saw a 2.58% rise last month. The broader market trends indicate a 1.9% increase over the past week alone, suggesting Apple's price movement aligns well with overall market growth. Product innovations, such as enhancements in software...

The United States market has shown robust performance, climbing 1.9% in the last 7 days and 12% over the past year, with earnings forecasted to grow by 14% annually. In this environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation potential and resilience in their financial metrics.

The United States market has experienced a notable increase, climbing 1.9% in the last week and rising 12% over the past year, with earnings anticipated to grow by 14% annually in the coming years. In this environment, identifying stocks that are trading below their fair value can offer potential opportunities for investors seeking to capitalize on future growth prospects.

BioMarin Pharmaceutical (NASDAQ:BMRN) has had a rough three months with its share price down 25%. We, however decided...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Harmonic Inc. ( NASDAQ:HLIT ), is not the largest company out there, but it saw a double-digit share price rise of over...

Many ON Semiconductor Corporation ( NASDAQ:ON ) insiders ditched their stock over the past year, which may be of...

With a median price-to-earnings (or "P/E") ratio of close to 18x in the United States, you could be forgiven for...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Synaptics Incorporated ( NASDAQ:SYNA ) shareholders should be happy to see the share price up 12% in the last month...

There wouldn't be many who think Evergy, Inc.'s ( NASDAQ:EVRG ) price-to-earnings (or "P/E") ratio of 18.1x is worth a...

Buying shares in the best businesses can build meaningful wealth for you and your family. And we've seen some truly...

Many investors define successful investing as beating the market average over the long term. But its virtually certain...

Key Insights The projected fair value for Xylem is US$161 based on 2 Stage Free Cash Flow to Equity Xylem's US$127...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Ironwood Pharmaceuticals, Inc. ( NASDAQ:IRWD ) shareholders are no doubt pleased to see that the share price has...